We are live on ! Find out more
GOVX icon

GeoVax Labs

10 hedge funds and large institutions have $798K invested in GeoVax Labs in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.22% less ownership

Funds ownership: 6.09% → 5.87% (-0.22%)

17% less funds holding

Funds holding: 12 → 10 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

76% less capital inflows, than outflows

Capital inflows: $10K | Capital outflows: $41.2K

Holders
10
Holders Change
-2
Holders Change %
-16.67%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$10K

GOVX Hedge Fund Activity: Q3 2023 in Review

10 of the 6,315 institutional investors tracked by Wall St. Rank reported a position in GeoVax Labs (GOVX) for Q3 2023, worth a combined $798K — down 10% from $886K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of GOVX and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was UBS Group, opening a new position worth an estimated $10K. The largest seller was Two Sigma Securities, exiting entirely with an estimated $20.2K sold.

  • 10 institutional investors held GeoVax Labs (GOVX) as of Q3 2023, down from 12 in Q2 2023.
  • Funds reported $798K of GeoVax Labs stock for Q3 2023, down 10% quarter-over-quarter.
  • 1 fund opened new GeoVax Labs positions in Q3 2023 and 3 closed out, a net change of -2 holders.
  • The largest GeoVax Labs buyer in Q3 2023 was UBS Group, an estimated $10K added.
  • The largest GeoVax Labs seller in Q3 2023 was Two Sigma Securities, an estimated $20.2K sold.

Based on aggregated 13F filings for Q3 2023.